BioPrime AgriSolutions, a leading innovator in sustainable agriculture, has received a crucial green light from the government to commercialize its high-performance microbial strains from the Bionexus library. This landmark approval unlocks the potential for BioPrime to deliver their new microbial solutions boasting a remarkable 2x performance improvement across eleven key areas, including mineralization, nitrogen fixation, nutrient use efficiency, and soil restoration.

With Government collaborative effort, it has registered these novel strains. This strategic move involves rigorous data generation encompassing safety, toxicology, and stability parameters, underscoring Bioprime’s commitment to ensuring the utmost quality and safety standards for its groundbreaking microbial offerings.

Beyond the approval for existing strains, the visionary approach extends to formulation innovation- a key differentiator in addressing long-standing challenges associated with microbe stability, in-field establishment, and ensuring plant-microbe communication. Previous formulations in the market have consistently fallen short of overcoming these hurdles, limiting the true potential of microbes in agriculture. Its commitment to overcoming historical bottlenecks in microbial activity reflects its dedicated efforts toward formulation innovation. Combining top-tier strains with cutting-edge formulations, it is poised to redefine the boundaries of microbial efficacy and deliver unparalleled performance.

Dr Shekhar Bhosle, co-founder & COO, BioPrime AgriSolutions, said, “The Government approval to introduce our high-performance microbial strains marks a pivotal moment in Bioprime’s journey. This endorsement validates our commitment to agricultural innovation and reinforces our vision for a future where sustainable practices redefine the agricultural landscape.”

Dr Amit Shinde, co-founder & COO, BioPrime AgriSolutions, said, “This is just the beginning for the Bionexus biologicals. Our library contains several hundred high potential novel strains e.g. 650+ Bacillus strains, 300+ Pseudomonas strains, 250+ endosymbiotic nitrogen fixers, 50+ Trichoderma strains. We are cementing partnerships with global MNCs for these strains commercialisation Besides we are very excited about our discovery of several potent microbial metabolites for antifungals, antibacterials, bioinsecticides and biopesticides.”